FIELD: chemical-pharmaceutical industry.
SUBSTANCE: group of inventions relates to the field of the chemical-pharmaceutical industry and medicine. Therapeutic-prophylactic agent has been described that exhibits immunotropic properties, in the form of sublingual orodispersible tablets characterized in that it includes the sodium salt of deoxyribonucleic acid as an active substance, and dehydrated dextrates and stearic acid or a pharmaceutically acceptable salt thereof in certain amounts as adjuvants. A method of producing said compound is also described.
EFFECT: agent activates antiviral, antifungal and antimicrobial immunity.
2 cl, 7 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SODIUM DEOXYRIBONUCLEATE SUPPOSITORIES, RECTAL AND VAGINAL | 2015 |
|
RU2601621C2 |
| METHOD OF PRODUCING ANTIVIRAL DRUG | 2020 |
|
RU2739186C1 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL DISEASES | 2021 |
|
RU2780252C1 |
| COLOSTRININ AND ITS APPLICATION | 1997 |
|
RU2217152C2 |
| ANTI-INFLAMMATORY COMPOSITION WITH PROLONGED ACTION FOR TREATING AIRWAY | 2015 |
|
RU2608126C1 |
| CHEEK POUCH (TRANSBUCCAL) PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2253442C1 |
| 1,2,4-TRIAZOL-3-YLTHIOGLYCOLIC ACID AMIDE WITH ANTIVIRAL ACTIVITY OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS, AND THEIR APPLICATION FOR FLU TREATMENT AND PREVENTION | 2014 |
|
RU2626003C2 |
| METHOD FOR PRODUCTION OF MEDICINAL PRODUCT BASED ON SODIUM DEOXYRIBONUCLEATE | 2020 |
|
RU2749007C1 |
| PHARMACEUTICAL ANTI-HERPETIC COMPOSITION | 2004 |
|
RU2291690C2 |
| SUCKING PILL CONTAINING HUMAN INTERFERON AND/OR INTERFERON INDUCTOR POSSESSING ANTIVIRAL ACTIVITY | 2004 |
|
RU2277932C2 |
